U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
VISILIZUMAB
H18SKU3289
Investigational
General
Names
11
Classification
1
Identifiers
10
Subunits
4
Related Substances
1
VISILIZUMAB
H18SKU3289
Investigational
General
Approval Year
Unknown
149,124
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
VISILIZUMAB
Official Name
English
visilizumab [INN]
Preferred Name
English
VISILIZUMAB [USAN]
Common Name
English
IMMUNOGLOBULIN G2 (HUMAN-MOUSE MONOCLONAL HUM291 .GAMMA.2-CHAIN ANTI-HUMAN ANTIGEN CD3), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUM291 .KAPPA.-CHAIN, DIMER
Common Name
English
HUM-291
Code
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
H18SKU3289
PRIMARY
USAN
KK-166
PRIMARY
SMS_ID
100000137406
PRIMARY
DRUG BANK
DB12053
PRIMARY
INN
8054
PRIMARY
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
H18SKU3289
VISILIZUMAB